arginine has been researched along with Right Ventricular Dysfunction in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (71.43) | 24.3611 |
| 2020's | 2 (28.57) | 2.80 |
| Authors | Studies |
|---|---|
| Aja, S; Coursen, J; Damico, RL; Gough, EK; Graham, D; Harlan, R; Hassoun, PM; Hsu, S; Kauffman, M; Kolb, TM; Mathai, SC; Roux, A; Simpson, CE; Suresh, K; Tedford, RJ | 1 |
| Alhussini, K; Bening, C; Benitez, RC; Keller, D; Leyh, R; Madrahimov, N; Radakovic, D; Sales, VL | 1 |
| Beloiartsev, A; Clish, CB; Dhakal, BP; Domos, C; Farrell, L; Gerszten, RE; Hemnes, AR; Lewis, GD; Ngo, D; Pappagianopoulos, PP; Pugh, ME; Shi, X; Sinha, S; Souza, A | 1 |
| Calvo, E; García-Álvarez, A; Vázquez, J | 1 |
| Dimitroula, H; Dimitroulas, T; Garyfallos, A; Giannakoulas, G; Karvounis, H; Koliakos, G; Papadopoulou, K; Parcharidou, D; Settas, L; Sfetsios, T; Styliadis, I | 1 |
| Dai, G; Ma, P; Pei, Y; Wang, X; Xu, Q; Yan, L; Zhang, W; Zhang, X; Zheng, P | 1 |
| Calvert, TJ; Chen, B; Chicoine, LG; Jin, Y; Liu, Y; Nelin, LD | 1 |
7 other study(ies) available for arginine and Right Ventricular Dysfunction
| Article | Year |
|---|---|
Metabolic profiling of in vivo right ventricular function and exercise performance in pulmonary arterial hypertension.
Topics: Arginine; Biomarkers; Familial Primary Pulmonary Hypertension; Humans; Kynurenine; Natriuretic Peptide, Brain; Pulmonary Arterial Hypertension; Ventricular Dysfunction, Right; Ventricular Function, Right | 2023 |
Clinically inapparent right heart dysfunction is associated with reduced myofilament force development in coronary artery disease.
Topics: Aged; Arginine; Asymptomatic Diseases; Biomarkers; C-Reactive Protein; Calcium; Coronary Artery Bypass; Coronary Artery Disease; Female; Humans; Male; Middle Aged; Myocardial Contraction; Myofibrils; Serum Albumin, Human; Serum Amyloid P-Component; Treatment Outcome; Ventricular Dysfunction, Right; Ventricular Function, Right | 2021 |
Metabolic Profiling of Right Ventricular-Pulmonary Vascular Function Reveals Circulating Biomarkers of Pulmonary Hypertension.
Topics: Adult; Aged; Animals; Arginine; Arterial Pressure; Biomarkers; Female; Humans; Hypertension, Pulmonary; Indoleamine-Pyrrole 2,3,-Dioxygenase; Male; Mice; Middle Aged; Nitric Oxide; Pulmonary Circulation; Purines; Reproducibility of Results; Statistics as Topic; Tricarboxylic Acids; Vascular Resistance; Ventricular Dysfunction, Right | 2016 |
The Quest for Metabolic Biomarkers of Pulmonary Hypertension.
Topics: Animals; Arginine; Female; Humans; Hypertension, Pulmonary; Indoleamine-Pyrrole 2,3,-Dioxygenase; Male; Nitric Oxide; Purines; Tricarboxylic Acids; Ventricular Dysfunction, Right | 2016 |
Left atrial volume and N-terminal pro-B type natriuretic peptide are associated with elevated pulmonary artery pressure in patients with systemic sclerosis.
Topics: Aged; Arginine; Biomarkers; Blood Pressure; Cross-Sectional Studies; Female; Follow-Up Studies; Heart Atria; Humans; Hypertension, Pulmonary; Male; Middle Aged; Multivariate Analysis; Natriuretic Peptide, Brain; Peptide Fragments; Predictive Value of Tests; Prospective Studies; Pulmonary Artery; Scleroderma, Systemic; Ultrasonography; Ventricular Dysfunction, Right | 2010 |
Rosuvastatin attenuates monocrotaline-induced pulmonary hypertension via regulation of Akt/eNOS signaling and asymmetric dimethylarginine metabolism.
Topics: Amidohydrolases; Animals; Arginine; Biomarkers; Body Weight; Fluorobenzenes; Gene Expression Regulation, Enzymologic; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Heart; Hypertension, Pulmonary; Lung; Male; Monocrotaline; Nitric Oxide Synthase Type III; Organ Size; Protein-Arginine N-Methyltransferases; Proto-Oncogene Proteins c-akt; Pyrimidines; Rats; Rats, Sprague-Dawley; Rosuvastatin Calcium; Signal Transduction; Sulfonamides; Ventricular Dysfunction, Right | 2011 |
Chronic hypoxia decreases arterial and venous compliance in isolated perfused rat lungs: an effect that is reversed by exogenous L-arginine.
Topics: Animals; Arginine; Blood Pressure; Chronic Disease; Citrulline; Compliance; Disease Models, Animal; Dose-Response Relationship, Drug; Enzyme Inhibitors; Hemodynamics; Hypertension, Pulmonary; Hypoxia; Lung; Nitric Oxide; Nitric Oxide Donors; Nitric Oxide Synthase; Perfusion; Pulmonary Artery; Pulmonary Veins; Rats; Rats, Sprague-Dawley; Time Factors; Vascular Resistance; Vasoconstriction; Ventricular Dysfunction, Right | 2013 |